Hemocompatibility testing is essential for evaluating the interactions of medical devices having contact with blood. Eurofins Medical Device Testing network of laboratories has more than 30 years of experience performing such biological safety testing of medical devices.
This guideline describes biological evaluation in general terms and requires testing strategies that mirror the device’s intended clinical use.
Medical devices having contact with circulating blood should be examined very thoroughly. For these devices the testing single endpoints using static systems may not be sufficient.
Testing should be performed by using dynamic systems, capable of evaluating the geometric influence on blood components. Physico-chemically comparable materials can exhibit different effects on hemocompatibility in clinical applications. Therefore, appropriate in vitro models should offer the possibility of dynamic testing in relation to high/low shear stress and the use of human whole blood with arbitrary anticoagulation.
The main benefit of dynamic test models is all five sub endpoints of ISO 10993-4 are evaluated accurately via ELISA based analysis of specific activation markers. Dynamic hemocompatibility tests include visualisation of cell and protein attachment to test material via scanning electron microscopy.
Our team of experts can perform the complete panel of hemocompatibility testing under GLP and non-GLP conditions.
*All in vivo assays are performed by our partner lab.